Vascular type 1A angiotensin II receptors control BP by regulating renal blood flow and urinary sodium excretion

Journal of the American Society of Nephrology

Volumn 26, Issue 12, 2015, Pages 2953-2962

  Sparks, Matthew A ^a   Stegbauer, Johannes ^a,b   Chen, Daian ^a   Gomez, Jose A ^a   Griffiths, Robert C ^a   Azad, Hooman A ^a   Herrera, Marcela ^a   Gurley, Susan B ^a   Coffman, Thomas M ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 1B RECEPTOR; CRE RECOMBINASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; NORADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CATECHOLAMINE; PHENTOLAMINE; VASOCONSTRICTOR AGENT;

ADRENERGIC SYSTEM; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CATECHOLAMINE URINE LEVEL; CONTROLLED STUDY; DEVELOPMENT; EMBRYO; GENE DELETION; GENE LOCUS; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; LOXP SITE; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SODIUM BALANCE; SODIUM EXCRETION; SODIUM RETENTION; SODIUM URINE LEVEL; URINARY EXCRETION; VASCULAR SMOOTH MUSCLE CELL; VASOCONSTRICTION; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE CELL; TRANSGENIC MOUSE; URINE; VASCULAR SMOOTH MUSCLE;

ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CATECHOLAMINES; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NATRIURESIS; PHENTOLAMINE; RECEPTOR, ANGIOTENSIN, TYPE 1; RENAL CIRCULATION; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84958233346     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014080816     Document Type: Article

References (50)

1. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H; LIFE Study Group: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 359: 995-1003, 2002
2. Matchar DB,McCrory DC,Orlando LA, PatelMR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN: Systematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med 148: 16-29, 2008
3. Sparks MA, Crowley SD, Gurley SB, MirotsouM, Coffman TM: Classical renin-angiotensin system in kidney physiology. Compr Physiol 4: 1201-1228, 2014
4. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 115: 1092-1099, 2005
5. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, SmithiesO, Le TH,Coffman TM: Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103: 17985-17990, 2006
6. Li H, Weatherford ET, Davis DR, Keen HL, Grobe JL, Daugherty A, Cassis LA, Allen AM, Sigmund CD: Renal proximal tubule angiotensin AT1A receptors regulate blood pressure. Am J Physiol Regul Integr Comp Physiol 301: R1067-R1077, 2011
7. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, Haase VH, Snouwaert JN, Le TH, McDonough AA, Koller BH, Coffman TM: AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab 13: 469-475, 2011
8. Guilluy C, Brégeon J, Toumaniantz G, Rolli-Derkinderen M, Retailleau K, Loufrani L, Henrion D, Scalbert E, Bril A, Torres RM, Offermanns S, Pacaud P, Loirand G: The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med 16: 183-190, 2010
9. Michael SK, Surks HK, Wang Y, Zhu Y, Blanton R, Jamnongjit M, Aronovitz M, Baur W, Ohtani K, Wilkerson MK, Bonev AD, Nelson MT, Karas RH,MendelsohnME:High blood pressure arising froma defect in vascular function. Proc Natl Acad Sci U S A 105: 6702-6707, 2008
10. McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, Chambon P, Hill MA, Dorrance AM, Mendelsohn ME, Jaffe IZ: Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med 18: 1429-1433, 2012
11. Earley L, Schrier R: Intrarenal control of sodium excretion by hemodynamics and physical factors. In: Handbook of Physiology: Renal Physiology, Washington,DC, American Physiological Society, 1973, pp 721-762
12. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L: A global doublefluorescent Cre reporter mouse. Genesis 45: 593-605, 2007
13. SparksMA, MakhanovaNA, Griffiths RC, Snouwaert JN, Koller BH,Coffman TM: Thromboxane receptors in smooth muscle promote hypertension, vascular remodeling, and sudden death. Hypertension 61: 166-173, 2013
14. Oliverio MI, Best CF, Smithies O, Coffman TM: Regulation of sodium balance and blood pressure by the AT(1A) receptor for angiotensin II. Hypertension 35: 550-554, 2000
15. WeinbergerMH: Pathogenesis of salt sensitivity of blood pressure. Curr Hypertens Rep 8: 166-170, 2006
16. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS: A mouse model of angiotensin II slow pressor response: Role of oxidative stress. J AmSoc Nephrol 13: 2860-2868, 2002
17. ItoM, Oliverio MI,Mannon PJ, Best CF,Maeda N, Smithies O, Coffman TM: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A 92: 3521-3525, 1995
18. Oliverio MI, Best CF, Kim HS, Arendshorst WJ, Smithies O, Coffman TM: Angiotensin II responses in AT1A receptor-deficient mice: A role for AT1B receptors in blood pressure regulation. Am J Physiol 272: F515-F520, 1997
19. Davisson RL, Yang G, Beltz TG, CassellMD, Johnson AK, Sigmund CD: The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res 83: 1047-1058, 1998
20. Davisson RL, Oliverio MI, Coffman TM, Sigmund CD: Divergent functions of angiotensin II receptor isoforms in thebrain. JClin Invest 106: 103-106, 2000
21. Ruan X, Oliverio MI, Coffman TM, Arendshorst WJ: Renal vascular reactivity in mice: AngII-induced vasoconstriction in AT1A receptor null mice. J Am Soc Nephrol 10: 2620-2630, 1999
22. Basso N, Terragno NA: History about the discovery of the reninangiotensin system. Hypertension 38: 1246-1249, 2001
23. Page IH, Helmer OM: A crystalline pressor substance (angiotonin) resulting from the reaction between renin and renin-activator. J ExpMed 71: 29-42, 1940
24. Touyz RM, Schiffrin EL: Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52: 639-672, 2000
25. Kai H, Fukui T, Lassigue B, Shah A, Minieri CA, Griendling KK: Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smoothmuscle cells. Mol Pharmacol 49: 96-104, 1996
26. Schiffrin EL: Vascular remodeling in hypertension: Mechanisms and treatment. Hypertension 59: 367-374, 2012
27. Mendelsohn ME: In hypertension, the kidney is not always the heart of the matter. J Clin Invest 115: 840-844, 2005
28. Guyton AC: Kidneys and fluids in pressure regulation. Small volume but large pressure changes. Hypertension 19[Suppl]: I2-I8, 1992
29. Kawasaki T, Delea CS, Bartter FC, Smith H: The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am JMed 64: 193-198, 1978
30. London GM, Levenson JA, London AM, Simon AC, Safar ME: Systemic compliance, renal hemodynamics, and sodium excretion in hypertension. Kidney Int 26: 342-350, 1984
31. Hollenberg NK, Adams DF: The renal circulation in hypertensive disease. Am J Med 60: 773-784, 1976
32. Martino JA, Earley LE: The effects of infusion of water on renal hemodynamics and the tubular reabsorption of sodium. J Clin Invest 46: 1229-1238, 1967
33. Martino JA, Earley LE: Demonstration of a role of physical factors as determinants of the natriuretic response to volume expansion. J Clin Invest 46: 1963-1978, 1967
34. Cowley AWJr, Roman RJ: The role of the kidney in hypertension. JAMA 275: 1581-1589, 1996
35. Carter AJ, Gardiner DG, Burges RA: Natriuretic activity of amlodipine, diltiazem, and nitrendipine in saline-loaded anesthetized dogs. J Cardiovasc Pharmacol 12[Suppl 7]: S34-S38, 1988
36. May CN, Evans RG: Frontiers in research series: Neural, hormonal and renal interactions in long-term blood pressure control II. Introduction. Clin Exp Pharmacol Physiol 37: 272-273, 2010
37. Touyz RM: Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: Role of angiotensin II. Exp Physiol 90: 449-455, 2005
38. Harrison-Bernard LM, Cook AK, Oliverio MI, Coffman TM: Renal segmental microvascular responses to ANG II in AT1A receptor null mice. Am J Physiol Renal Physiol 284: F538-F545, 2003
39. Zhou Y, Chen Y, Dirksen WP, Morris M, Periasamy M: AT1b receptor predominantly mediates contractions in major mouse blood vessels. Circ Res 93: 1089-1094, 2003
40. Kooner JS,May CN, Peart S, Mathias CJ: Separation of peripheral and central cardiovascular actions of angiotensin II.AmJ Physiol 273: H2620-H2626, 1997
41. Lazartigues E, Dunlay SM, Loihl AK, Sinnayah P, Lang JA, Espelund JJ, Sigmund CD, Davisson RL: Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice. Circ Res 90: 617-624, 2002
42. Kouyama R, Suganami T, Nishida J, Tanaka M, Toyoda T, Kiso M, Chiwata T,Miyamoto Y, Yoshimasa Y, Fukamizu A, HoriuchiM, Hirata Y, Ogawa Y: Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology 146: 3481-3489, 2005
43. Sparks MA, Parsons KK, Stegbauer J, Gurley SB, Vivekanandan-Giri A, Fortner CN, Snouwaert J, Raasch EW, Griffiths RC, Haystead TA, Le TH, Pennathur S, Koller B, Coffman TM: Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension. Hypertension 57: 577-585, 2011
44. Nelson RD, Stricklett P,Gustafson C, Stevens A, Ausiello D, Brown D, Kohan DE: Expression of an AQP2 Cre recombinase transgene in kidney and male reproductive systemof transgenicmice.AmJ Physiol 275:C216-C226, 1998
45. Solway J, Seltzer J, Samaha FF, Kim S, Alger LE, Niu Q, Morrisey EE, Ip HS, Parmacek MS: Structure and expression of a smooth muscle cellspecific gene, SM22 alpha. J Biol Chem270: 13460-13469, 1995
46. Chang L, Villacorta L, Zhang J, Garcia-Barrio MT, Yang K, Hamblin M, Whitesall SE, D'Alecy LG, Chen YE: Vascular smooth muscle cellselective peroxisome proliferator-activated receptor-gamma deletion leads to hypotension. Circulation 119: 2161-2169, 2009
47. He Y, Zhang H, Yu L,GunelM, Boggon TJ, Chen H,MinW: Stabilization of VEGFR2 signaling by cerebral cavernousmalformation 3 is critical for vascular development. Sci Signal 3: ra26, 2010
48. Oliverio MI, KimHS, ItoM, Le T, Audoly L, BestCF,Hiller S, Kluckman K, Maeda N, SmithiesO, Coffman TM: Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A 95: 15496-15501, 1998
49. Butz GM, Davisson RL: Long-term telemetric measurement of cardiovascular parameters in awake mice: A physiological genomics tool. Physiol Genomics 5: 89-97, 2001
50. Francois H, Athirakul K, Mao L, Rockman H, Coffman TM: Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 43: 364-369, 2004